Announced
GSK to dispose the 2.5% stake in Haleon.
Synopsis
GSK, a multinational pharmaceutical and biotechnology company, agreed to dispose the 2.5% stake in Haleon, a consumer healthcare company. Financial terms were not disclosed.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.